Market Cap 28.77M
Revenue (ttm) 0.00
Net Income (ttm) -71.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 341,300
Avg Vol 408,402
Day's Range N/A - N/A
Shares Out 16.25M
Stochastic %K 7%
Beta 2.83
Analysts Strong Sell
Price Target $12.67

Company Profile

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic sp...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 549 1400
Address:
2200 Bridge Pkwy, Suite 102, Redwood City, United States
FIREINSP
FIREINSP Nov. 14 at 7:17 PM
$JSPR And another ATL. This seems to be a daily occurrence...
0 · Reply
elmono
elmono Nov. 14 at 10:22 AM
$JSPR Maybe shorting hedge funds can push this sub 1…..looking good
1 · Reply
FIREINSP
FIREINSP Nov. 13 at 8:10 PM
$JSPR Another ATL...
0 · Reply
Mario19860
Mario19860 Nov. 13 at 7:41 PM
0 · Reply
FIREINSP
FIREINSP Nov. 13 at 2:35 PM
$JSPR Another losing day…
0 · Reply
BioRich
BioRich Nov. 12 at 8:53 PM
$JSPR Hopefully rebounds sooner than later. Underwater on this one. Think there's hope, just a little tight right now. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
1 · Reply
UnoffensiveName
UnoffensiveName Nov. 12 at 8:33 PM
$JSPR have they addressed the bad batch issue?
1 · Reply
Stmkr
Stmkr Nov. 12 at 5:59 PM
$JSPR "we are encouraged by the determination that the results seen in these two cohorts do not appear to be related to any issues with drug substance or drug product." why is this encouraging? this was the best scenario...
1 · Reply
elmono
elmono Nov. 12 at 5:14 PM
$JSPR when asthma data? Must be great, right?
0 · Reply
FIREINSP
FIREINSP Nov. 12 at 2:32 PM
$JSPR Another down day…
0 · Reply
Latest News on JSPR
Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem

Jul 7, 2025, 1:25 PM EDT - 4 months ago

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem


FIREINSP
FIREINSP Nov. 14 at 7:17 PM
$JSPR And another ATL. This seems to be a daily occurrence...
0 · Reply
elmono
elmono Nov. 14 at 10:22 AM
$JSPR Maybe shorting hedge funds can push this sub 1…..looking good
1 · Reply
FIREINSP
FIREINSP Nov. 13 at 8:10 PM
$JSPR Another ATL...
0 · Reply
Mario19860
Mario19860 Nov. 13 at 7:41 PM
0 · Reply
FIREINSP
FIREINSP Nov. 13 at 2:35 PM
$JSPR Another losing day…
0 · Reply
BioRich
BioRich Nov. 12 at 8:53 PM
$JSPR Hopefully rebounds sooner than later. Underwater on this one. Think there's hope, just a little tight right now. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
1 · Reply
UnoffensiveName
UnoffensiveName Nov. 12 at 8:33 PM
$JSPR have they addressed the bad batch issue?
1 · Reply
Stmkr
Stmkr Nov. 12 at 5:59 PM
$JSPR "we are encouraged by the determination that the results seen in these two cohorts do not appear to be related to any issues with drug substance or drug product." why is this encouraging? this was the best scenario...
1 · Reply
elmono
elmono Nov. 12 at 5:14 PM
$JSPR when asthma data? Must be great, right?
0 · Reply
FIREINSP
FIREINSP Nov. 12 at 2:32 PM
$JSPR Another down day…
0 · Reply
BioTechChap
BioTechChap Nov. 11 at 10:07 PM
$JSPR SMH, incompetence at best, AGAIN(!). Not a faulty batch, once again faulty patient selection. Now we understand why CMO was kicked out promptly: “Then we looked at the tryptase levels, and the tryptase levels were down, consistent with what we've seen before. That meant that they had active antibody on board.” “Right now, the leading hypothesis is, it may be as simple as, or it may be multifactorial. It may be that these 10 patients don't have mast cell-mediated disease.”
3 · Reply
Messerschmittbf109
Messerschmittbf109 Nov. 11 at 9:58 PM
$JSPR dead man walking …game over
1 · Reply
elmono
elmono Nov. 11 at 9:46 PM
$GUTS $JSPR $NRXP Shit stains in my portfoliio. Annoying
1 · Reply
DarkOrb
DarkOrb Nov. 11 at 9:34 PM
$JSPR From the company's presentation after the close today at Stifel, it sounded like they are trying to get enough good data to sell the company, since they do not have the funds to run the Ph2b study they plan to start sometime next year. Martell still seemed highly confident the drug works despite the busted trial where apparently 10 patients at 5 different sites did not have the expected clinical response. Funding into the second half of 2026.
1 · Reply
FIREINSP
FIREINSP Nov. 11 at 4:32 PM
$JSPR this is headed for delisting.
2 · Reply
Messerschmittbf109
Messerschmittbf109 Nov. 11 at 4:12 PM
$JSPR the hedges and house of affairs are the worst of tthis …system
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 3:25 PM
RBC Capital has adjusted their stance on Jasper Therapeutics ( $JSPR ), setting the rating to Sector Perform with a target price of 5 → 4.
0 · Reply
Messerschmittbf109
Messerschmittbf109 Nov. 11 at 3:24 PM
$CRVO $JSPR boys .. but really are you thinking positive in this turd full of thi eves ?????
0 · Reply
DarkOrb
DarkOrb Nov. 11 at 2:20 AM
$JSPR For those who didn't see, these weasels snuck out their Q3 results today without a call. Link to press release below. They can't figure out why they had the busted trial, but they think the drug lot was good. Update on trials coming later this year and in Q1 "Cash runway through the first half of 2026" https://ir.jaspertherapeutics.com/news-releases/news-release-details/jasper-therapeutics-reports-third-quarter-2025-financial-results
1 · Reply
Messerschmittbf109
Messerschmittbf109 Nov. 10 at 8:42 PM
$JSPR How many wages can these beg .g ars still steal? $CRVO …..
1 · Reply
FIREINSP
FIREINSP Nov. 10 at 8:41 PM
$JSPR Couldn’t even hold its gains…
0 · Reply
Messerschmittbf109
Messerschmittbf109 Nov. 10 at 5:01 PM
$CRVO $JSPR the last two bio stocks red today 💩🤡💩
0 · Reply